Request Demo
Last update 26 Aug 2025
Romiplostim biosimilar(Intas Biopharmaceuticals Ltd.)
Last update 26 Aug 2025
Overview
Basic Info
Drug Type Peptibody, Biosimilar |
Synonyms Romiplostim Biosimilar (Intas Biopharmaceuticals Ltd.), 罗米司亭生物类似药（Intas Biopharmaceuticals Ltd.） |
Target |
Action agonists |
Mechanism TPO receptor agonists(Thrombopoietin receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 116979
The sequence is quoted from: *****
Related
3
Clinical Trials associated with Romiplostim biosimilar(Intas Biopharmaceuticals Ltd.)CTRI/2021/08/035609
A prospective, single-arm, multicentre study to assess safety and efficacy of Romy�® (Romiplostim Powder for Injection) (Intas Pharmaceuticals Ltd., India) in patients with chronic refractory immune (idiopathic) thrombocytopenic purpura (ITP)
CTRI/2017/11/010620
A Prospective, Assessor-blind, Randomized, Parallel group Clinical Trial to Assess Single Dose Pharmacokinetics and Pharmacodynamics of Inj. Romiplostim from Intas Pharmaceuticals Ltd. and Inj. Romiplostim of Amgen Inc. in Patients with Chronic Refractory Immune (Idiopathic) Thrombocytopenic Purpura - NA
CTRI/2015/09/006197
A Prospective, Open-label, Multi-centric Study to Evaluate the Efficacy and Safety of Inj. Romiplostim of Intas Pharmaceuticals Ltd. in Adult Indian Patients with Chronic Refractory Idiopathic Thrombocytopenic Purpura. - NA
100 Clinical Results associated with Romiplostim biosimilar(Intas Biopharmaceuticals Ltd.)
Login to view more data
100 Translational Medicine associated with Romiplostim biosimilar(Intas Biopharmaceuticals Ltd.)
Login to view more data
100 Patents (Medical) associated with Romiplostim biosimilar(Intas Biopharmaceuticals Ltd.)
Login to view more data
100 Deals associated with Romiplostim biosimilar(Intas Biopharmaceuticals Ltd.)
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Purpura, Thrombocytopenic, Idiopathic | Phase 3 | - | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free